ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Biomarker Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-32R5863
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Biomarker Market Insights Forecast to 2028
BUY CHAPTERS

Global Oncology Biomarker Market Insights, Forecast to 2030

Code: QYRE-Auto-32R5863
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Bristol–Myers Squibb
Eli Lilly and Company
F Hoffmann La Roche Ltd
Genomic Health
GlaxoSmithKline PLC
Novartis
Merck
Pfizer Inc
QIAGEN N V

Oncology Biomarker Market

A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.
Market Analysis and Insights: Global Oncology Biomarker Market
The global Oncology Biomarker market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oncology Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oncology Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oncology Biomarker include Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, GlaxoSmithKline plc, Novartis AG, Merck & Co. and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oncology Biomarker is widely used in various fields, such as Diagnostics, Drug Discovery And Development, Prognostics and Risk Assessment, etc. Diagnostics provides greatest supports to the Oncology Biomarker industry development. In 2023, global % revenue of Oncology Biomarker went into Diagnostics filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oncology Biomarker market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncology Biomarker, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncology Biomarker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Biomarker revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Biomarker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncology Biomarker revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Oncology Biomarker Market Report

Report Metric Details
Report Name Oncology Biomarker Market
Segment by Type
Segment by Application
  • Diagnostics
  • Drug Discovery And Development
  • Prognostics
  • Risk Assessment
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, GlaxoSmithKline plc, Novartis AG, Merck & Co., Pfizer, Qiagen N.V.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Oncology Biomarker in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Biomarker companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Biomarker revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Oncology Biomarker Market report?

Ans: The main players in the Oncology Biomarker Market are Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, GlaxoSmithKline plc, Novartis AG, Merck & Co., Pfizer, Qiagen N.V.

What are the Application segmentation covered in the Oncology Biomarker Market report?

Ans: The Applications covered in the Oncology Biomarker Market report are Diagnostics, Drug Discovery And Development, Prognostics, Risk Assessment, Others

What are the Type segmentation covered in the Oncology Biomarker Market report?

Ans: The Types covered in the Oncology Biomarker Market report are Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others

Recommended Reports

Cancer Diagnostics

Biomarkers & Testing

Cancer Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Prostate Cancer
1.2.6 Stomach Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Oncology Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery And Development
1.3.4 Prognostics
1.3.5 Risk Assessment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Biomarker Market Perspective (2019-2030)
2.2 Global Oncology Biomarker Growth Trends by Region
2.2.1 Oncology Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Oncology Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Oncology Biomarker Market Dynamics
2.3.1 Oncology Biomarker Industry Trends
2.3.2 Oncology Biomarker Market Drivers
2.3.3 Oncology Biomarker Market Challenges
2.3.4 Oncology Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oncology Biomarker by Players
3.1.1 Global Oncology Biomarker Revenue by Players (2019-2024)
3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oncology Biomarker, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oncology Biomarker Market Concentration Ratio
3.4.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2023
3.5 Global Key Players of Oncology Biomarker Head office and Area Served
3.6 Global Key Players of Oncology Biomarker, Product and Application
3.7 Global Key Players of Oncology Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Biomarker Breakdown Data by Type
4.1 Global Oncology Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Oncology Biomarker Forecasted Market Size by Type (2025-2030)
5 Oncology Biomarker Breakdown Data by Application
5.1 Global Oncology Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Oncology Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Biomarker Market Size (2019-2030)
6.2 North America Oncology Biomarker Market Size by Type
6.2.1 North America Oncology Biomarker Market Size by Type (2019-2024)
6.2.2 North America Oncology Biomarker Market Size by Type (2025-2030)
6.2.3 North America Oncology Biomarker Market Share by Type (2019-2030)
6.3 North America Oncology Biomarker Market Size by Application
6.3.1 North America Oncology Biomarker Market Size by Application (2019-2024)
6.3.2 North America Oncology Biomarker Market Size by Application (2025-2030)
6.3.3 North America Oncology Biomarker Market Share by Application (2019-2030)
6.4 North America Oncology Biomarker Market Size by Country
6.4.1 North America Oncology Biomarker Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oncology Biomarker Market Size by Country (2019-2024)
6.4.3 North America Oncology Biomarker Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oncology Biomarker Market Size (2019-2030)
7.2 Europe Oncology Biomarker Market Size by Type
7.2.1 Europe Oncology Biomarker Market Size by Type (2019-2024)
7.2.2 Europe Oncology Biomarker Market Size by Type (2025-2030)
7.2.3 Europe Oncology Biomarker Market Share by Type (2019-2030)
7.3 Europe Oncology Biomarker Market Size by Application
7.3.1 Europe Oncology Biomarker Market Size by Application (2019-2024)
7.3.2 Europe Oncology Biomarker Market Size by Application (2025-2030)
7.3.3 Europe Oncology Biomarker Market Share by Application (2019-2030)
7.4 Europe Oncology Biomarker Market Size by Country
7.4.1 Europe Oncology Biomarker Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oncology Biomarker Market Size by Country (2019-2024)
7.4.3 Europe Oncology Biomarker Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oncology Biomarker Market Size (2019-2030)
8.2 China Oncology Biomarker Market Size by Type
8.2.1 China Oncology Biomarker Market Size by Type (2019-2024)
8.2.2 China Oncology Biomarker Market Size by Type (2025-2030)
8.2.3 China Oncology Biomarker Market Share by Type (2019-2030)
8.3 China Oncology Biomarker Market Size by Application
8.3.1 China Oncology Biomarker Market Size by Application (2019-2024)
8.3.2 China Oncology Biomarker Market Size by Application (2025-2030)
8.3.3 China Oncology Biomarker Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oncology Biomarker Market Size (2019-2030)
9.2 Asia Oncology Biomarker Market Size by Type
9.2.1 Asia Oncology Biomarker Market Size by Type (2019-2024)
9.2.2 Asia Oncology Biomarker Market Size by Type (2025-2030)
9.2.3 Asia Oncology Biomarker Market Share by Type (2019-2030)
9.3 Asia Oncology Biomarker Market Size by Application
9.3.1 Asia Oncology Biomarker Market Size by Application (2019-2024)
9.3.2 Asia Oncology Biomarker Market Size by Application (2025-2030)
9.3.3 Asia Oncology Biomarker Market Share by Application (2019-2030)
9.4 Asia Oncology Biomarker Market Size by Region
9.4.1 Asia Oncology Biomarker Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oncology Biomarker Market Size by Region (2019-2024)
9.4.3 Asia Oncology Biomarker Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oncology Biomarker Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oncology Biomarker Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oncology Biomarker Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Biomarker Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
11.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Oncology Biomarker Introduction
11.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2019-2024)
11.3.5 Eli Lilly and Company Recent Developments
11.4 F.Hoffmann-La Roche Ltd.
11.4.1 F.Hoffmann-La Roche Ltd. Company Details
11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
11.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2019-2024)
11.4.5 F.Hoffmann-La Roche Ltd. Recent Developments
11.5 Genomic Health
11.5.1 Genomic Health Company Details
11.5.2 Genomic Health Business Overview
11.5.3 Genomic Health Oncology Biomarker Introduction
11.5.4 Genomic Health Revenue in Oncology Biomarker Business (2019-2024)
11.5.5 Genomic Health Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
11.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2019-2024)
11.6.5 GlaxoSmithKline plc Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Oncology Biomarker Introduction
11.7.4 Novartis AG Revenue in Oncology Biomarker Business (2019-2024)
11.7.5 Novartis AG Recent Developments
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Oncology Biomarker Introduction
11.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2019-2024)
11.8.5 Merck & Co. Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oncology Biomarker Introduction
11.9.4 Pfizer Revenue in Oncology Biomarker Business (2019-2024)
11.9.5 Pfizer Recent Developments
11.10 Qiagen N.V.
11.10.1 Qiagen N.V. Company Details
11.10.2 Qiagen N.V. Business Overview
11.10.3 Qiagen N.V. Oncology Biomarker Introduction
11.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2019-2024)
11.10.5 Qiagen N.V. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott Laboratories
Bristol–Myers Squibb
Eli Lilly and Company
F Hoffmann La Roche Ltd
Genomic Health
GlaxoSmithKline PLC
Novartis
Merck
Pfizer Inc
QIAGEN N V
List of Tables
    Table 1. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Lung Cancer
    Table 3. Key Players of Breast Cancer
    Table 4. Key Players of Colorectal Cancer
    Table 5. Key Players of Prostate Cancer
    Table 6. Key Players of Stomach Cancer
    Table 7. Key Players of Others
    Table 8. Global Oncology Biomarker Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Oncology Biomarker Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Oncology Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Oncology Biomarker Market Share by Region (2019-2024)
    Table 12. Global Oncology Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Oncology Biomarker Market Share by Region (2025-2030)
    Table 14. Oncology Biomarker Market Trends
    Table 15. Oncology Biomarker Market Drivers
    Table 16. Oncology Biomarker Market Challenges
    Table 17. Oncology Biomarker Market Restraints
    Table 18. Global Oncology Biomarker Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Oncology Biomarker Revenue Share by Players (2019-2024)
    Table 20. Global Top Oncology Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2023)
    Table 21. Global Oncology Biomarker Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Oncology Biomarker Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Oncology Biomarker, Headquarters and Area Served
    Table 24. Global Key Players of Oncology Biomarker, Product and Application
    Table 25. Global Key Players of Oncology Biomarker, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Oncology Biomarker Revenue Market Share by Type (2019-2024)
    Table 29. Global Oncology Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Oncology Biomarker Revenue Market Share by Type (2025-2030)
    Table 31. Global Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Oncology Biomarker Revenue Share by Application (2019-2024)
    Table 33. Global Oncology Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Oncology Biomarker Revenue Share by Application (2025-2030)
    Table 35. North America Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Oncology Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Oncology Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Oncology Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Oncology Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Oncology Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Oncology Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Oncology Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Oncology Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Oncology Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Oncology Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Oncology Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Oncology Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Oncology Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Oncology Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Oncology Biomarker Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Oncology Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Oncology Biomarker Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Oncology Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Oncology Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Abbott Laboratories Company Details
    Table 68. Abbott Laboratories Business Overview
    Table 69. Abbott Laboratories Oncology Biomarker Product
    Table 70. Abbott Laboratories Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 71. Abbott Laboratories Recent Developments
    Table 72. Bristol-Myers Squibb Company Details
    Table 73. Bristol-Myers Squibb Business Overview
    Table 74. Bristol-Myers Squibb Oncology Biomarker Product
    Table 75. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 76. Bristol-Myers Squibb Recent Developments
    Table 77. Eli Lilly and Company Company Details
    Table 78. Eli Lilly and Company Business Overview
    Table 79. Eli Lilly and Company Oncology Biomarker Product
    Table 80. Eli Lilly and Company Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 81. Eli Lilly and Company Recent Developments
    Table 82. F.Hoffmann-La Roche Ltd. Company Details
    Table 83. F.Hoffmann-La Roche Ltd. Business Overview
    Table 84. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product
    Table 85. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 86. F.Hoffmann-La Roche Ltd. Recent Developments
    Table 87. Genomic Health Company Details
    Table 88. Genomic Health Business Overview
    Table 89. Genomic Health Oncology Biomarker Product
    Table 90. Genomic Health Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 91. Genomic Health Recent Developments
    Table 92. GlaxoSmithKline plc Company Details
    Table 93. GlaxoSmithKline plc Business Overview
    Table 94. GlaxoSmithKline plc Oncology Biomarker Product
    Table 95. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 96. GlaxoSmithKline plc Recent Developments
    Table 97. Novartis AG Company Details
    Table 98. Novartis AG Business Overview
    Table 99. Novartis AG Oncology Biomarker Product
    Table 100. Novartis AG Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 101. Novartis AG Recent Developments
    Table 102. Merck & Co. Company Details
    Table 103. Merck & Co. Business Overview
    Table 104. Merck & Co. Oncology Biomarker Product
    Table 105. Merck & Co. Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 106. Merck & Co. Recent Developments
    Table 107. Pfizer Company Details
    Table 108. Pfizer Business Overview
    Table 109. Pfizer Oncology Biomarker Product
    Table 110. Pfizer Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 111. Pfizer Recent Developments
    Table 112. Qiagen N.V. Company Details
    Table 113. Qiagen N.V. Business Overview
    Table 114. Qiagen N.V. Oncology Biomarker Product
    Table 115. Qiagen N.V. Revenue in Oncology Biomarker Business (2019-2024) & (US$ Million)
    Table 116. Qiagen N.V. Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Oncology Biomarker Market Share by Type: 2023 VS 2030
    Figure 3. Lung Cancer Features
    Figure 4. Breast Cancer Features
    Figure 5. Colorectal Cancer Features
    Figure 6. Prostate Cancer Features
    Figure 7. Stomach Cancer Features
    Figure 8. Others Features
    Figure 9. Global Oncology Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Oncology Biomarker Market Share by Application: 2023 VS 2030
    Figure 11. Diagnostics Case Studies
    Figure 12. Drug Discovery And Development Case Studies
    Figure 13. Prognostics Case Studies
    Figure 14. Risk Assessment Case Studies
    Figure 15. Others Case Studies
    Figure 16. Oncology Biomarker Report Years Considered
    Figure 17. Global Oncology Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Oncology Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Oncology Biomarker Market Share by Region: 2023 VS 2030
    Figure 20. Global Oncology Biomarker Market Share by Players in 2023
    Figure 21. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2023
    Figure 23. North America Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Oncology Biomarker Market Share by Type (2019-2030)
    Figure 25. North America Oncology Biomarker Market Share by Application (2019-2030)
    Figure 26. North America Oncology Biomarker Market Share by Country (2019-2030)
    Figure 27. United States Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Oncology Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Oncology Biomarker Market Share by Type (2019-2030)
    Figure 31. Europe Oncology Biomarker Market Share by Application (2019-2030)
    Figure 32. Europe Oncology Biomarker Market Share by Country (2019-2030)
    Figure 33. Germany Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Oncology Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Oncology Biomarker Market Share by Type (2019-2030)
    Figure 41. China Oncology Biomarker Market Share by Application (2019-2030)
    Figure 42. Asia Oncology Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Oncology Biomarker Market Share by Type (2019-2030)
    Figure 44. Asia Oncology Biomarker Market Share by Application (2019-2030)
    Figure 45. Asia Oncology Biomarker Market Share by Region (2019-2030)
    Figure 46. Japan Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Oncology Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Oncology Biomarker Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Oncology Biomarker Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Oncology Biomarker Market Share by Country (2019-2030)
    Figure 56. Brazil Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Oncology Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 64. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 65. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 66. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 67. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 68. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 69. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 70. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 71. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Cancer Biomarker Market Insights Forecast to 2030
Global Cancer Molecular Biomarkers Market Research Report 2024
Global Commercializing Biomarkers Market Research Report 2025
Global Clinical Biomarkers Market Research Report 2024
Global Clinical Biomarker Testing Market Research Report 2024
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biomarker Testing for Cancer Market Research Report 2024
Global Tumor Marker Test Kits Market Research Report 2025
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Protein Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Biomarkers Detection Market Research Report 2024
Medical Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Noninvasive Cancer Biomarkers Market Research Report 2024
Global Biomarker Market Research Report 2024
Global Liquid Biopsy Services Market Research Report 2025
Global Cardiac Biomarkers Testing Market Insights Forecast to 2030
Global Circulating Biomarker for Liquid Biopsy Market Research Report 2024
Global Targeted Biomarker Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions